CDC reforming COVID-19 guidance … Nearly three-quarters of the U.S. now estimated to be immune to omicron variant … Brain synapse destruction culprit behind Alzheimer’s cognitive decline … Treatment...
Study: ‘Cognitive frailty’ may be result of aging — not the brain changes found in dementia
By
Alicia Lasek
Jan 11, 2022
Reduced cognitive function without substantial memory complaints may be a normal part of aging and not an early sign of Alzheimer’s disease or other dementias, investigators say.
Enrichment activities activate genes that help seniors resist cognitive decline
By
Amy Novotney
Nov 08, 2021
Spending time on intellectually stimulating activities appears to activate a gene family known as MEF2, which controls a genetic program in the brain that promotes resistance to cognitive decline. That’s...
Having a good listener in one’s life may help slow cognitive decline: study
By
Alicia Lasek
Aug 18, 2021
Older adults who have regular interactions with active listeners are more likely to have cognitive functioning that contradicts evidence of dementia-related brain changes, a new study finds.
Memory loss may linger eight months after mild coronavirus infection, study finds
By
Alicia Lasek
Aug 17, 2021
The results suggest that COVID-19 may not really be a mild disease, no matter its course, investigators say. They also raise the question of whether current home-treatment strategies are optimal for long-term...
Nursing home residents with, without COVID-19 experienced cognitive decline during pandemic
By
Donna Shryer
May 14, 2021
Quarantine measures associated with COVID-19 appear to affect cognitive performance in nursing home residents and older adults regardless of whether an actual SARS-CoV-2 diagnosis exists.
Clinical briefs for Friday, March 26
By
Alicia Lasek
Mar 26, 2021
California and Florida prepare to open vaccine access to all adults … Common Alzheimer’s treatment linked to slower cognitive decline …Flu shot associated with fewer, less severe COVID cases...
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
Study confirms link between high blood pressure and dementia in seniors
By
Alicia Lasek
Dec 17, 2020
High blood pressure is tied to lower global cognitive and memory test scores, a long-term study shows.
Social isolation may be a precursor to memory loss
By
Alicia Lasek
Jan 27, 2020
Social isolation not only contributes to memory loss in older age, but affects men and women differently, according to a new study.